In contrast, researchers at National Jewish Medical and Research Center discovered that the important cell cycle kinase, cdk6, plays an important role in tumor cell growth and was absent or present in decreased amount in all breast tumor-derived cell lines examined. Therefore, cdk6 may be useful as a marker of tumor cell growth especially in patients with breast cancer.
Histologic studies using tissue from breast cancer patients are in progress.
Demonstrating reliability of cdk6 as a predictor of in vivo tumor cell growth. Other publications in press and submitted. No part of this publication may be redistributed in any form without prior permission. Terms and conditions for users . Privacy policy .